Ashley M Hopkins (Ashley Hopkins)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 34

Top Topics

Small Cell Lung Cancer

Cross Sectional

Top Venues

BMJ (Clinical research ed.)

This page only lists publications with an associated author ORCID identifier.

Publications

Bradley D Menz, Nicole M Kuderer, Stephen Bacchi, Natansh D Modi, Benjamin Chin-Yee, Tiancheng Hu, Ceara Rickard, Mark Haseloff, Agnes Vitry, Ross A McKinnon, Ganessan Kichenadasse, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis. BMJ (Clinical research ed.) 384 (2024)
Shrirajh Satheakeerthy, Brandon Stretton, Andrew E C Booth, Sarah Howson, Shaun Evans, Joshua G Kovoor, Keith McNeil, Ashley M Hopkins, Kathryn Zeitz, Alasdair Leslie, Peter Psaltis, Aashray Gupta, Sheryn Tan, Melissa Teo, Andrew Vanlint, Weng O Chan, Andrew C W Zannettino, Patrick G O'Callaghan, John Maddison, Samuel Gluck, Toby R Gilbert, Stephen Bacchi
Push or pull? Digital notification platform implementation reduces dysglycaemia. Internal medicine journal (2024)
Bradley D Menz, Nicole M Kuderer, Stephen Bacchi, Natansh D Modi, Benjamin Chin-Yee, Tiancheng Hu, Ceara Rickard, Mark Haseloff, Agnes Vitry, Ross A McKinnon, Ganessan Kichenadasse, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis. BMJ (Clinical research ed.) 384 (2024)
Bradley D Menz, Nicole M Kuderer, Stephen Bacchi, Natansh D Modi, Benjamin Chin-Yee, Tiancheng Hu, Ceara Rickard, Mark Haseloff, Agnes Vitry, Ross A McKinnon, Ganessan Kichenadasse, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis. BMJ (Clinical research ed.) 384 (2024)
Michael J Sorich, Bradley D Menz, Ashley M Hopkins
Quality and safety of artificial intelligence generated health information. BMJ (Clinical research ed.) 384 (2024)
Bradley D Menz, Nicole M Kuderer, Stephen Bacchi, Natansh D Modi, Benjamin Chin-Yee, Tiancheng Hu, Ceara Rickard, Mark Haseloff, Agnes Vitry, Ross A McKinnon, Ganessan Kichenadasse, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis. BMJ (Clinical research ed.) 384 (2024)
Bradley D Menz, Nicole M Kuderer, Stephen Bacchi, Natansh D Modi, Benjamin Chin-Yee, Tiancheng Hu, Ceara Rickard, Mark Haseloff, Agnes Vitry, Ross A McKinnon, Ganessan Kichenadasse, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis. BMJ (Clinical research ed.) 384 (2024)
Joshua G Kovoor, Harry Smallbone, Alexander Jenkins, Brandon Stretton, Sanjana Santhosh, Jonathan H W Jacobsen, Aashray K Gupta, Ammar Zaka, Silas D Nann, Melinda Jiang, Yuchen Luo, Caitlyn Withers, Sara Ataie, Nasim Nematzadeh, Leigh R Warren, Matthew Marshall-Webb, WengOnn Chan, Keith McNeil, Samuel Gluck, Richard Turner, Melanie Tan, Tobin South, Toby R Gilbert, Ashley M Hopkins, Andrew S Vanlint, Gregory M Sweetman, Timothy R Bates, Amandeep Hansra, Stephen Bacchi
The future is bright: artificial intelligence for trainee medical officers in Australia and New Zealand. Internal medicine journal (2024)
Michael J Sorich, Bradley D Menz, Ashley M Hopkins
Quality and safety of artificial intelligence generated health information. BMJ (Clinical research ed.) 384 (2024)
Michael J Sorich, Bradley D Menz, Ashley M Hopkins
Quality and safety of artificial intelligence generated health information. BMJ (Clinical research ed.) 384 (2024)
Michael J Sorich, Bradley D Menz, Ashley M Hopkins
Quality and safety of artificial intelligence generated health information. BMJ (Clinical research ed.) 384 (2024)
Arkady T Manning-Bennett, Julie Cervesi, Pierre-Alain Bandinelli, Michael J Sorich, Ashley M Hopkins
Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials. Biomedicines 11 (2) (2023)
Giang T Lam, Carmela Martini, Tiffany Brooks, Sarita Prabhakaran, Ashley M Hopkins, Ben S-Y Ung, Jingying Tang, Maria C Caruso, Robert D Brooks, Ian R D Johnson, Alexandra Sorvina, Shane M Hickey, Litsa Karageorgos, Sonja Klebe, John J O'Leary, Douglas A Brooks, Jessica M Logan
Insights into Melanoma Clinical Practice: A Perspective for Future Research. Cancers 15 (18) (2023)
Arkady T Manning-Bennett, Julie Cervesi, Pierre-Alain Bandinelli, Michael J Sorich, Ashley M Hopkins
Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials. Biomedicines 11 (2) (2023)
Ashley M Hopkins, Jessica M Logan, Ganessan Kichenadasse, Michael J Sorich
Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift. JNCI cancer spectrum 7 (2) (2023)
Jessica M Logan, Ashley M Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R D Johnson, Shane M Hickey, Ben S-Y Ung, Joanna Lazniewska, Robert D Brooks, Courtney R Moore, Maria C Caruso, Litsa Karageorgos, Cara M Martin, Sharon A O'Toole, Laura Bogue Edgerton, Mark P Ward, Mark Bates, Stavros Selemidis, Adrian Esterman, Sheena Heffernan, Helen Keegan, Sarah Ní Mhaolcatha, Roisin O'Connor, Victoria Malone, Marguerite Carter, Katie Ryan, Andres Clarke, Nathan Brady, Sonja Klebe, Hemamali Samaratunga, Brett Delahunt, Michael J Sorich, Kim Moretti, Lisa M Butler, John J O'Leary, Douglas A Brooks
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1. Cancers 15 (12) (2023)
Natansh D Modi, Ganessan Kichenadasse, Tammy C Hoffmann, Mark Haseloff, Jessica M Logan, Areti A Veroniki, Rebecca L Venchiarutti, Amelia K Smit, Haitham Tuffaha, Harindra Jayasekara, Arkady Manning-Bennet, Erin Morton, Ross A McKinnon, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies. BMC medicine 21 (1) (2023)
Jessica M Logan, Ashley M Hopkins, Carmela Martini, Alexandra Sorvina, Prerna Tewari, Sarita Prabhakaran, Chelsea Huzzell, Ian R D Johnson, Shane M Hickey, Ben S-Y Ung, Joanna Lazniewska, Robert D Brooks, Courtney R Moore, Maria C Caruso, Litsa Karageorgos, Cara M Martin, Sharon A O'Toole, Laura Bogue Edgerton, Mark P Ward, Mark Bates, Stavros Selemidis, Adrian Esterman, Sheena Heffernan, Helen Keegan, Sarah Ní Mhaolcatha, Roisin O'Connor, Victoria Malone, Marguerite Carter, Katie Ryan, Andres Clarke, Nathan Brady, Sonja Klebe, Hemamali Samaratunga, Brett Delahunt, Michael J Sorich, Kim Moretti, Lisa M Butler, John J O'Leary, Douglas A Brooks
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1. Cancers 15 (12) (2023)
Arkady T Manning-Bennett, Julie Cervesi, Pierre-Alain Bandinelli, Michael J Sorich, Ashley M Hopkins
Prognostic Associations of Concomitant Antibiotic Use in Patients with Advanced NSCLC Treated with Atezolizumab: Sensitivity Analysis of a Pooled Investigation of Five Randomised Control Trials. Biomedicines 11 (2) (2023)
Lauren A Newman, Zivile Useckaite, Jillian Johnson, Michael J Sorich, Ashley M Hopkins, Andrew Rowland
Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease. Biomedicines 10 (1) (2022)
Ashley M Hopkins, Ganessan Kichenadasse, Ross A McKinnon, Ahmad Y Abuhelwa, Jessica M Logan, Sarah Badaoui, Christos S Karapetis, Andrew Rowland, Michael J Sorich
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150. British journal of cancer (2021)
Jessica M Logan, Douglas A Brooks, Andrew Rowland, Michael J Sorich, Ashley M Hopkins
Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events. Journal of oncology 2021 (2021)
Warit Ruanglertboon, Michael J Sorich, Ashley M Hopkins, Andrew Rowland
Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing. Pharmaceuticals (Basel, Switzerland) 14 (5) (2021)
Ashley M Hopkins, Ganessan Kichenadasse, Ahmad Y Abuhelwa, Ross A McKinnon, Andrew Rowland, Michael J Sorich
Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 13 (5) (2021)
Ashley M Hopkins, Ganessan Kichenadasse, Ahmad Y Abuhelwa, Ross A McKinnon, Andrew Rowland, Michael J Sorich
Reply to Auclin et al. Comment on "Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176". Cancers 13 (15) (2021)
Michael D Wiese, Ashley M Hopkins, Catherine King, Mihir D Wechalekar, Anita Lee, Llewellyn Spargo, Robert Metcalf, Leah McWilliams, Catherine L Hill, Leslie G Cleland, Susanna M Proudman
Precision Medicine With Leflunomide: Consideration of the DHODH Haplotype and Plasma Teriflunomide Concentration and Modification of Outcomes in Patients With Rheumatoid Arthritis. Arthritis care & research 73 (7) (2021)
Ashley M Hopkins, Bradley D Menz, Michael D Wiese, Ganessan Kichenadasse, Howard Gurney, Ross A McKinnon, Andrew Rowland, Michael J Sorich
Nuances to precision dosing strategies of targeted cancer medicines. Pharmacology research & perspectives 8 (4) (2021)
Kenneth H Wills, Stephen J Behan, Michael J Nance, Jessica L Dawson, Thomas M Polasek, Ashley M Hopkins, Madelé van Dyk, Andrew Rowland
Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure. Pharmaceutics 14 (1) (2021)
Ahmad Y Abuhelwa, Ganessan Kichenadasse, Ross A McKinnon, Andrew Rowland, Ashley M Hopkins, Michael J Sorich
Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer. Cancers 13 (9) (2021)
Ashley M Hopkins, Jordan Wagner, Ganessan Kichenadasse, Natansh Modi, Andrew Rowland, Michael J Sorich
Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy. International journal of cancer 147 (11) (2020)
Ashley M Hopkins, Akash D Rathod, Andrew Rowland, Ganessan Kichenadasse, Michael J Sorich
Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials. BMC cancer 20 (1) (2020)
Ashley M Hopkins, Madele Van Dyk, Andrew Rowland, Michael J Sorich
Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial data. Pigment cell & melanoma research 32 (4) (2019)
Ashley M Hopkins, Andrew Rowland, Michael J Sorich
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability. BMC medicine 16 (1) (2018)
Ashley M Hopkins, Jessica Wojciechowski, Ahmad Y Abuhelwa, Stuart Mudge, Richard N Upton, David J R Foster
Population Pharmacokinetic Model of Doxycycline Plasma Concentrations Using Pooled Study Data. Antimicrobial agents and chemotherapy 61 (3) (2017)